Sunday, June 10

Clinical Trial Update | Science-in-Progress | Simultaneous Sessions III | Hematology-in-Focus Sessions | Simultaneous Sessions IV | Clinical Trial Update

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room: Mozart I

CLINICAL IMPLICATIONS OF FLT3 IN ACUTE MYELOID LEUKEMIA

Chair: F. Lo Coco (University Tor Vergata, Rome, Italy)
  • MUTATIONS AS PROGNOSTIC AND PREDICTIVE FACTORS IN AML
    K. Döhner (University Hospital of Ulm, Ulm, Germany)
     
  • PRE-CLINICAL AND CLINICAL IMPACT OF FLT3 INHIBITORS
    A. Burnett (University of Wales, College of Medicine, Cardiff, United Kingdom)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room: Mozart II

DEVELOPMENT OF NEW MONOCLONAL ANTIBODIES IN NHL

Chair: G. Salles (Centre Hospitalier Lyon-Sud, Lyon, France)
  • PHARMACOGENETICS OF THERAPEUTIC ANTIBODIES: IMPLICATION OF FCGR3A POLYMORPHISM
    V. Suraud (Université Francois-Rabelais de Tours, Tours, France)
  • WHAT HAVE WE LEARNT FROM CLINICAL TRIALS OF MONOCLONAL ANTIBODIES IN LYMPHOMA?
    A. Hagenbeek (Academic Medical Center, Amsterdam, The Netherlands)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room: Mozart III

ZAP-70 IN CHRONIC LYMPHOCYTIC LEUKEMIA

Chair: H. Döhner (University Hospital, Internal Med.III, Ulm, Germany)
  • ZAP-70 IN B-CELL RECEPTOR SIGNALLING
    T. Kipps (University of California, San Diego, USA)
  • IS THERE A ROLE OF ZAP-70 FOR GUIDING TREATMENT DECISIONS?
    F. Bosch (Hospital Clinic, Barcelona, Spain)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room: Strauss I

HOT TOPICS IN TRANSFUSION MEDICINE

Chair: B. Mansouri (University Hospital, Inselspital, Bern, Switzerland)
  • NON-INVASIVE PRENATAL DIAGNOSIS OF FETAL RHESUS D
    C. van der Schoot (Sanquin, Amsterdam, The Netherlands)
  • THE BLOODGEN PROJECT: TOWARDS MASS SCALE COMPREHENSIVE GENOTYPING OF BLOOD DONORS IN THE EUROPEAN UNION AND BEYOND
    N. Avent (Bristol Genomics Research Institute, Bristol, United Kingdom)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room: Strauss II

THROMBOTIC THROMBOCYTOPENIC PURPURA

Chair: B. Lämmle (Klinik und Poliklinik fur Hämatologie, Bern, Switzerland)
  • THE REGULATION OF ADAMTS 13-VWF INTERACTION
    R. De Cristofaro (Catholic University School of Medicine, Rome, Italy)
  • MANAGEMENT OF TTP
    S. Machin (University College London, London, United Kingdom)

HEMATOLOGY-IN-FOCUS SESSION

09.30 - 10.15 hours, Room: Strauss III

CONGENITAL NEUTROPENIAS

Chair: N. Borregaard (University of Copenhagen, Rigshospitalet, Copenhagen, Denmark)
  • GENETIC CONTROL OF NEUTROPHIL PRODUCTION: NEW INSIGHT INTO SEVERE CONGENITAL NEUTROPENIA
    K. Welte (Medical School Hanover, Hanover, Germany)
  • MOLECULAR BASIS OF SHWACHMAN-DIAMOND SYNDROME
    C. Wong (University of Cambridge, Cambridge, United Kingdom)


Top of page ]


EHA Executive Office, Westblaak 71, 3012 KE Rotterdam, The Netherlands | Phone: (+31) 10-4361760 | Email: